Spinal epidural hematoma occurrence in the absence of known risk factors: A case series

Cullen, David J.; Bogdanov, E A; Htut, Nyan

doi:10.1016/j.jclinane.2003.12.007

Cited by 26 publications

(17 citation statements)

References 13 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These will be further discussed below. It should be noted, however, that haemorrhage may also occur in patients without any known risk factors 34,35 …”

Section: Resultsmentioning

confidence: 99%

Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Breivik

Bang

Jalonen

et al. 2009

Acta Anaesthesiol Scand

154

161

View full text Add to dashboard Cite

show abstract

“…These will be further discussed below. It should be noted, however, that haemorrhage may also occur in patients without any known risk factors 34,35 …”

Section: Resultsmentioning

confidence: 99%

Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Breivik

Bang

Jalonen

et al. 2009

Acta Anaesthesiol Scand

154

161

View full text Add to dashboard Cite

show abstract

“…Concerning the timing of the onset of SEH, lumbar pain occurred on the removal of the catheter, and then the nervous symptoms gradually became exacerbated; therefore, hemorrhage may have occurred via the catheter removal, resulting in hematoma formation. The pathogenesis of hematomas has been clarifi ed in many patients, as demonstrated in our patient, but not in some others [10,11]. In our patient, cilostazol may have been involved in the pathogenesis.…”

Section: Discussionmentioning

confidence: 50%

Spinal epidural hematoma following epidural catheter removal during antiplatelet therapy with cilostazol

2008

View full text Add to dashboard Cite

A 90-year-old man underwent emergency thrombectomy for acute occlusion of the right femoral and popliteal arteries. After an epidural catheter (used for intraoperative/postoperative management) was removed, a spinal epidural hematoma involving the Th12 to L3 areas developed. Emergency removal of the hematoma and decompression of the spinal cord were performed. Possibly, the hematoma had developed due to therapy with an antiplatelet agent, cilostazol, which had been started on the first postoperative day, and due to the removal of the catheter, on the third postoperative day, in addition to the patient's advanced age. This case may be the first report of spinal epidural hematoma associated with both cilostazol and epidural anesthesia. From the time course in this patient, important knowledge of drug actions and follow-up may be gained for determining the timing of catheter removal in a patient receiving antiplatelet therapy with cilostazol.

show abstract

“…Symptoms of SEH were almost always immediate after manipulation. Spontaneous SEH is very uncommon, 13 and its cause is unknown. The incidence of SEH is somewhat higher in the presence of coagulopathy or in patients undergoing anticoagulation therapy.…”

Section: Discussionmentioning

confidence: 99%

Spinal Epidural Hematoma After Spinal Manipulative Therapy in a Patient Undergoing Anticoagulant Therapy: A Case Report

Whedon

Quebada

Roberts

et al. 2006

Journal of Manipulative and Physiological Therapeutics

View full text Add to dashboard Cite

Spinal epidural hematoma occurrence in the absence of known risk factors: A case series

Cited by 26 publications

References 13 publications

Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Spinal epidural hematoma following epidural catheter removal during antiplatelet therapy with cilostazol

Spinal Epidural Hematoma After Spinal Manipulative Therapy in a Patient Undergoing Anticoagulant Therapy: A Case Report

Contact Info

Product

Resources

About